When your doctor writes you a prescription for TYSABRI, both of you will review, complete, and sign the enrollment form for the TOUCH® Prescribing Program. This is to make sure that you are informed about the benefits and risks of treatment with TYSABRI, including the risk of progressive multifocal leukoencephalopathy (PML). In fact, your doctor, nurse, pharmacy, and infusion center are all part of the TOUCH program. TOUCH ensures that you communicate closely with your heathcare team to monitor PML risk over time, so you can decide whether TYSABRI remains right for you.
Since 2006, everyone taking TYSABRI in the United States has been part of the TOUCH Prescribing Program, which tracks every person taking TYSABRI.
Once you are enrolled in the TOUCH Prescribing Program, you will receive several important phone calls that will help you get started on TYSABRI as smoothly and as quickly as possible. These calls will come from a Support Coordinator from Biogen and from your TOUCH-authorized infusion center and pharmacy. You'll see either 919-993-7000 or ‘Unknown’ on your caller ID, so be sure to answer. These calls will:
TOUCH-authorized centers are staffed by nurses who are committed to your safety. They are committed to the TOUCH program and will educate you on the potential benefits and risks of TYSABRI, ensure that you have read and understand the TYSABRI Medication Guide, and answer any questions about your infusion. They will ask you questions before each TYSABRI infusion to make sure TYSABRI is still right for you.
Talk to the nurse before each infusion. Share any new or ongoing medical conditions such as: